Guided Therapeutics (GTHP) Payables (2010 - 2026)
Guided Therapeutics (GTHP) posted Payables of $2.8 million for Q4 2025, up 9.34% sequentially from $2.5 million in Q3 2025, and up 23.73% YoY from $2.2 million in Q4 2024.
Guided Therapeutics (GTHP) Payables (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Payables for 16 years, with the latest figure at $2.8 million in Q4 2025.
- Quarterly Payables rose 23.73% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 23.73% YoY) and the FY2025 annual result came in at $2.8 million, up 23.73% from the prior year.
- Payables rose to $2.8 million in Q4 2025 per GTHP's latest filing, from $2.5 million in the prior quarter.
- Over five years, Payables peaked at $2.8 million in Q3 2022 and troughed at $1.9 million in Q1 2024.
- A 5-year average of $2.3 million and a median of $2.3 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2021 and 2022: Payables fell 28.4% in 2021, then increased 25.95% in 2022.
- Over 5 years, Payables stood at $2.5 million in 2021, then declined by 11.1% to $2.2 million in 2022, then slipped by 11.23% to $2.0 million in 2023, then gained by 12.15% to $2.2 million in 2024, then advanced by 23.73% to $2.8 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $2.8 million, $2.5 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 5.89 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 2.00 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.51 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 587.50 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 2.45 Mn |